• Alecensa 150 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  ALECTINIB HYDROCHLORIDE	161,33 mg

  ATC: L01E L01ED L01ED03

• Avastin 25 mg/ml concentrate for infusion solution

  Form: solution for infusion, concentrate

  Active substance	Dosage
  BEVACIZUMAB	25 mg

  ATC: L01F L01FG L01FG01

• Avastin 25 mg/ml concentrate for infusion solution

  Form: solution for infusion, concentrate

  Active substance	Dosage
  BEVACIZUMAB	25 mg

  ATC: L01F L01FG L01FG01

• CellCept 250 mg capsules

  Form: capsules, hard

  Active substance	Dosage
  MYCOPHENOLATE MOFETIL	250 mg

  ATC: L04A L04AA L04AA06

• CellCept 500 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  MYCOPHENOLATE MOFETIL	500 mg

  ATC: L04A L04AA L04AA06

• CellCept 500 mg powder for concentrate for solution for infusion

  Form: powder for concentrate for solution for infusion

  Active substance	Dosage
  MYCOPHENOLATE MOFETIL	500 mg

  ATC: L04A L04AA L04AA06

• Cellcept 1 g/5 ml powder for oral suspension

  Form: powder for preparation of oral suspension

  Active substance	Dosage
  MYCOPHENOLATE MOFETIL	1 g

  ATC: L04A L04AA L04AA06

• Columvi 10 mg concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  GLOFITAMAB	10 mg

  ATC: L01F L01FX L01FX28

• Columvi 2.5 mg concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  GLOFITAMAB	2,5 mg

  ATC: L01F L01FX L01FX28

• Cotellic 20 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  COBIMETINIB	20 mg

  ATC: L01E L01EE L01EE02

• Enspryng 120 mg solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  SATRALIZUMAB	120 mg

  ATC: L04A L04AC L04AC19

• Erivedge 150 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  VISMODEGIB	150 mg

  ATC: L01X L01XJ L01XJ01

• Esbriet 267 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  PIRFENIDONE	267 mg

  ATC: L04A L04AX L04AX05

• Esbrinet 801 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  PIRFENIDONE	801 mg

  ATC: L04A L04AX L04AX05

• Evrysdi 0.75 mg/ml powder for oral solution

  Form: powder for oral solution

  Active substance	Dosage
  RISDIPLAM	0,75 mg

  ATC: M09A M09AX M09AX10

• Evrysdi 5 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  RISDIPLAM	5 mg

  ATC: M09A M09AX M09AX10

• Gazyvaro 1000 mg concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  OBINUTUZUMAB	1000 mg

  ATC: L01F L01FA L01FA03

• Hemlibra 150 mg/ml solution for injection

  Form: solution for injection

  Active substance	Dosage
  EMICIZUMAB	150 mg

  ATC: B02B B02BX B02BX06

• Hemlibra 30 mg/ml solution for injection

  Form: solution for injection

  Active substance	Dosage
  EMICIZUMAB	30 mg

  ATC: B02B B02BX B02BX06

• Herceptin 150 mg powder for concentrate for solution for infusion

  Form: powder for concentrate for solution for infusion

  Active substance	Dosage
  TRASTUZUMAB	150 mg

  ATC: L01F L01FD L01FD01

• Herceptin 600 mg solution for injection in vial

  Form: solution for injection

  Active substance	Dosage
  TRASTUZUMAB	600 mg

  ATC: L01F L01FD L01FD01

• Kadcyla 100 mg powder for concentrate for solution for infusion

  Form: powder for concentrate for solution for infusion

  Active substance	Dosage
  TRASTUZUMAB EMTANSINE	20 mg

  ATC: L01F L01FD L01FD03

• Kadcyla 160 mg powder for concentrate for infusion solution

  Form: powder for concentrate for solution for infusion

  Active substance	Dosage
  TRASTUZUMAB EMTANSINE	20 mg

  ATC: L01F L01FD L01FD03

• Lunsumio 1 mg concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  MOSUNETUZUMAB	1 mg

  ATC: L01F L01FX L01FX25

• Lunsumio 30 mg concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  MOSUNETUZUMAB	30 mg

  ATC: L01F L01FX L01FX25

• MabThera 100 mg concentrate for solution for infusion

  Form: solution for injection

  Active substance	Dosage
  RITUXIMAB	10 mg

  ATC: L01F L01FA L01FA01

• MabThera 1400 mg solution for subcutaneous injection

  Form: solution for injection

  Active substance	Dosage
  RITUXIMAB	120 mg

  ATC: L01F L01FA L01FA01

• Mabthera 500 mg concentrate for solution for infusion

  Form: solution for injection

  Active substance	Dosage
  RITUXIMAB	50 mg

  ATC: L01F L01FA L01FA01

• Mircera 100 micrograms/0.3 ml solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  Methoxy-Polyethylene Glycol-Epoetin Beta	100 µg

  ATC: B03X B03XA B03XA03

• Mircera 120 micrograms/0.3 ml solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  Methoxy-Polyethylene Glycol-Epoetin Beta	120 µg

  ATC: B03X B03XA B03XA03

• Mircera 150 micrograms/0.3 ml solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  Methoxy-Polyethylene Glycol-Epoetin Beta	150 µg

  ATC: B03X B03XA B03XA03

• Mircera 200 micrograms/0.3 ml solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  Methoxy-Polyethylene Glycol-Epoetin Beta	200 µg

  ATC: B03X B03XA B03XA03

• Mircera 250 micrograms/0.3 ml solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  Methoxy-Polyethylene Glycol-Epoetin Beta	250 µg

  ATC: B03X B03XA B03XA03

• Mircera 30 micrograms/0.3 ml solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  Methoxy-Polyethylene Glycol-Epoetin Beta	30 µg

  ATC: B03X B03XA B03XA03

• Mircera 50 micrograms/0.3 ml solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  Methoxy-Polyethylene Glycol-Epoetin Beta	50 µg

  ATC: B03X B03XA B03XA03

• Mircera 75 micrograms/0.3 ml solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  Methoxy-Polyethylene Glycol-Epoetin Beta	75 µg

  ATC: B03X B03XA B03XA03

• NeoRecormon 10000 IU solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  EPOETIN BETA	10 kilo UI

  ATC: B03X B03XA B03XA01

• NeoRecormon 30000 IU/solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  EPOETIN BETA	30000 UI

  ATC: B03X B03XA B03XA01

• Neorecormon 500 IU solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  EPOETIN BETA	500 UI

  ATC: B03X B03XA B03XA01

• Ocrevus 300 mg concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  OCRELIZUMAB	30 mg

  ATC: L04A L04AG L04AG08

• Perjeta 420 mg concentrate for infusion solution

  Form: solution for infusion, concentrate

  Active substance	Dosage
  PERTUZUMAB	30,0 mg

  ATC: L01F L01FD L01FD02

• Phesgo 1200 mg/600 mg solution for injection

  Form: solution for injection

  Active substance	Dosage
  PERTUZUMAB	1200 mg
  TRASTUZUMAB	600 mg

  ATC: L01F L01FY L01FY01

• Phesgo 600 mg/600 mg solution for injection

  Form: solution for injection

  Active substance	Dosage
  PERTUZUMAB	600 mg
  TRASTUZUMAB	600 mg

  ATC: L01F L01FY L01FY01

• Piasky 340 mg solution for injection and for infusion

  Form: solution for injection and for infusion

  Active substance	Dosage
  CROVALIMAB	340 mg

  ATC: L04A L04AJ L04AJ07

• Polivy 140 mg powder for concentrate for infusion solution

  Form: powder for concentrate for solution for infusion

  Active substance	Dosage
  POLATUZUMAB VEDOTINA	140 mg

  ATC: L01F L01FX L01FX14

• Polivy 30 mg powder for concentrate for solution for infusion

  Form: powder for concentrate for solution for infusion

  Active substance	Dosage
  POLATUZUMAB VEDOTINA	30 mg

  ATC: L01F L01FX L01FX14

• RoActemra 162 mg solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  TOCILIZUMAB	162 mg

  ATC: L04A L04AC L04AC07

• Roactemra 162 mg solution for injection in pre-filled pen

  Form: solution for injection in pre-filled pen

  Active substance	Dosage
  TOCILIZUMAB	162 mg

  ATC: L04A L04AC L04AC07

• Roactemra 20 mg/ml concentrate for solution for infusion

  Form: solution for injection

  Active substance	Dosage
  TOCILIZUMAB	20 mg

  ATC: L04A L04AC L04AC07

• Roactemra 20 mg/ml concentrate for solution for infusion

  Form: solution for injection

  Active substance	Dosage
  TOCILIZUMAB	20 mg

  ATC: L04A L04AC L04AC07